Mevaseret Zion, Israel

Amos Panet

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Theravir Management L.p., Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.. Active years: 2007-2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Amos Panet. Retrieved from https://idiyas.com/inventor/amos-panet-gz4n47kb

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 4.2

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2007-2009

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Mind of Amos Panet

Introduction

Amos Panet, an accomplished inventor based in Mevaseret Zion, Israel, has made significant contributions to the field of cancer treatment through his innovative research. With two patents to his name, Panet is at the forefront of developing novel methodologies for combating tumors, particularly in patients who are unresponsive to conventional therapies.

Latest Patents

Panet's latest patents highlight his groundbreaking work with Newcastle Disease Virus (NDV) in treating cancer. The first patent, titled "Compositions of NDV and methods of use thereof for treatment of cancer," outlines methods for inducing tumor regression by administering a pharmaceutical composition that includes a lentogenic strain of NDV, specifically the clonal strain NDV HUJ. This invention is particularly beneficial for patients who do not respond to standard anti-cancer therapies.

The second patent, "Compositions and methods for treatment of cancer," further explores the use of lentogenic viral strains in cancer treatment. It elaborates on the biological activities of a preferred strain of NDV, and it discloses methods for treating cancer by applying a clonal NDV strain directly to tumors. Additionally, this patent details innovative applications of isolated viral glycoproteins and polynucleotides for cancer treatment, showcasing Panet's commitment to advancing medical science.

Career Highlights

Amos Panet has held prominent positions in various research environments, notably with Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. and Theravir Management L.P. His work at these institutions has provided a solid foundation for his groundbreaking research and inventions.

Collaborations

Throughout his career, Panet has collaborated with notable professionals in his field, including Zichria Zakay-Rones and Charles S. Irving. These collaborations have enhanced his research output and contributed to the successful development of his patented inventions.

Conclusion

Amos Panet exemplifies the innovative spirit that drives progress in medical research. His inventions have the potential to change the landscape of cancer treatment, offering hope to patients who have exhausted their therapeutic options. As he continues to push the boundaries of scientific discovery, Panet's work will undoubtedly leave a lasting impact on the field of oncology and beyond.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…